OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
Hongsheng Zhang, Jintao Mi, Xin Qi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Hongsheng Zhang, Jintao Mi, Xin Qi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Showing 11 citing articles:
CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
Hanghang Xie, Xiaowei Xi, Ting Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Hanghang Xie, Xiaowei Xi, Ting Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche
Jayanta Mondal, Junfeng Zhang, Qing Feng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Jayanta Mondal, Junfeng Zhang, Qing Feng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Recent Advances in Immunotherapy for Breast Cancer: A Review
Qian-Er Wen, Liang Li, Rui-Qi Feng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 497-516
Open Access | Times Cited: 5
Qian-Er Wen, Liang Li, Rui-Qi Feng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 497-516
Open Access | Times Cited: 5
Divide and Conquer—Targeted Therapy for Triple-Negative Breast Cancer
Milica Nedeljković, Ana Vuletić, Katarina Mirjačić Martinović
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1396-1396
Open Access
Milica Nedeljković, Ana Vuletić, Katarina Mirjačić Martinović
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1396-1396
Open Access
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Immunotherapy in the Treatment of Triple-negative Breast Cancer: the Impact and Potential of the TME
Shuoming Chen, Sihan Zhou
MedScien (2024) Vol. 1, Iss. 7
Open Access
Shuoming Chen, Sihan Zhou
MedScien (2024) Vol. 1, Iss. 7
Open Access
Bio-inspired Nanomaterials in Cancer Theranostics
Monika Kaushik, Sanjesh Kumar, Mansi Singh, et al.
(2024), pp. 95-123
Closed Access
Monika Kaushik, Sanjesh Kumar, Mansi Singh, et al.
(2024), pp. 95-123
Closed Access
Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa
Izuchukwu F. Okpalanwaka, Francis I Anazodo, Zimuzor L Chike-Aliozor, et al.
Cureus (2024)
Open Access
Izuchukwu F. Okpalanwaka, Francis I Anazodo, Zimuzor L Chike-Aliozor, et al.
Cureus (2024)
Open Access
Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment
Lingpeng Tang, Dandan Wang, Ting Hu, et al.
Cancer Drug Resistance (2024)
Open Access
Lingpeng Tang, Dandan Wang, Ting Hu, et al.
Cancer Drug Resistance (2024)
Open Access
A combination of lymphatic drug delivery of anti‐CTLA ‐4 antibody and local radiotherapy for solid‐tumor treatment
Koki Takagi, Ariunbuyan Sukhbaatar, Yohei Inaba, et al.
Cancer Science (2024)
Open Access
Koki Takagi, Ariunbuyan Sukhbaatar, Yohei Inaba, et al.
Cancer Science (2024)
Open Access
Immunological tolerance in breast cancer: some reasons for development
Е. V. Kayukova, E. S. Bolotov
Advances in molecular oncology (2024) Vol. 11, Iss. 3, pp. 24-31
Open Access
Е. V. Kayukova, E. S. Bolotov
Advances in molecular oncology (2024) Vol. 11, Iss. 3, pp. 24-31
Open Access
